HSP90AA1 and Parkinson disease: Hsp90 is a potential target to prevent protein accumulation in multiple neurodegenerative proteinopathies, including tauopathies, amyloid beta [76,77], poly-glutamine repeat expansion disorders, and Parkinson’s disease [78–80].